Merrimack Pharmaceuticals Approves Liquidation and Dividend

Merrimack Pharmaceuticals Inc. (MACK) just unveiled an announcement.

Merrimack Pharmaceuticals, Inc. stockholders have overwhelmingly voted to approve the company’s liquidation and dissolution, with a substantial majority supporting the proposal in a Special Meeting held virtually. Following this approval, the company announced a significant liquidating cash dividend of $15.10 per share, expected to be paid shortly before Merrimack’s delisting from NASDAQ. While the future may hold additional distributions contingent on certain milestones, the company cautions that these forward-looking statements are subject to change and uncertainty.

See more data about MACK stock on TipRanks’ Stock Analysis page.